Guardant Health, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Revenue $313k
$49.8m +15812.32%
$90.6m +81.85%
$214.4m +136.52%
$286.7m +33.75%
$373.7m +30.32%
$449.5m +20.31%
$563.9m +25.45%
$739.0m +31.04%
$982.0m +32.88%
$1.2b +20.48%
Cost of revenue $294k $227.1m
$289.8m +27.64%
$349.0m +20.43%
$413.9m +18.61%
GROSS PROFIT $19k $336.9m
$449.2m +33.34%
$633.0m +40.91%
$769.2m +21.51%
Research and development expense $10.9m $25.6m $50.7m $86.3m $149.9m $263.2m $373.8m $367.2m $347.8m $364.2m $375.8m
Sales and marketing expense $26.2m $32.5m $53.5m $78.3m $106.5m $191.9m $299.8m $295.2m $364.9m $494.7m
General and administrative expense $52k $36.8m $36.2m $61.4m $192.8m $206.6m $164.0m $155.8m $180.1m $211.4m $233.8m
Total costs and operating expenses $69.1m $126.5m $183.6m $296.7m $541.7m $784.7m $993.9m $1.1b $1.2b $1.4b
Total operating expenses $106k $1.7b
Loss from operations ($87k)
($76.6m) -88318.53%
($92.9m) -21.32%
($82.4m) +11.37%
($254.9m) -209.51%
($411.0m) -61.21%
($544.4m) -32.45%
($564.7m) -3.74%
($443.6m) +21.45%
($437.2m) +1.43%
Interest expense $3.0m ($2.7m) ($1.3m) ($1.2m) ($4.8m) ($2.6m) ($2.6m) ($2.6m) ($2.6m) ($3.9m) $4.8m
Interest income ($324k) $2.2m $5.3m $13.7m $10.2m $3.9m $6.1m $35.4m $53.7m $34.1m $38.8m
Other income (expense), net $1k ($1.1m) $4.7m $88k $3.6m $25.2m ($12.8m) $53.2m ($42.6m) ($10.5m) ($18.2m)
Total other expense ($324k)
Loss before (benefit from) provision for income taxes ($410k) ($83.2m) ($84.2m) ($69.7m) ($245.9m) ($384.5m) ($653.4m) ($478.8m) ($435.1m) ($417.5m)
(Benefit from) provision for income taxes $6k $7k $38k ($1.9m) $379k $300k $1.1m $685k $1.3m ($1.3m)
Net loss ($410k) ($83.2m) ($85.1m) ($75.7m) ($246.3m) ($384.8m) ($654.6m) ($479.4m) ($436.4m) ($416.3m)
Net loss per share, basic (in usd per share) ($0) ($1) ($3) ($4) ($6) ($4) ($4) ($3)
Net loss per share, diluted (in usd per share) ($0) ($1) ($3) ($4) ($6) ($4) ($4) ($3)
Weighted-average shares used in computing net loss per share, basic (in shares) ($0) ($1) ($3) ($4) ($6) ($4) ($4) ($3)
Weighted-average shares used in computing net loss per share, diluted (in shares) ($0) ($1) ($3) ($4) ($6) ($4) ($4) ($3)
Other operating expense $0 $0 $83.4m $0 $0
Professional Fees $52k
Stock-Based Compensation Expense $2k

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.